True North Advisors LLC Sells 222 Shares of Colgate-Palmolive (NYSE:CL)

True North Advisors LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 3.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,964 shares of the company’s stock after selling 222 shares during the quarter. True North Advisors LLC’s holdings in Colgate-Palmolive were worth $723,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in CL. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in Colgate-Palmolive in the third quarter worth $339,000. SL Advisors LLC purchased a new position in Colgate-Palmolive in the third quarter valued at about $190,000. Brookstone Capital Management raised its stake in shares of Colgate-Palmolive by 11.7% during the 3rd quarter. Brookstone Capital Management now owns 17,366 shares of the company’s stock worth $1,803,000 after acquiring an additional 1,814 shares in the last quarter. Trust Co of Kansas boosted its position in shares of Colgate-Palmolive by 8.4% in the 3rd quarter. Trust Co of Kansas now owns 15,405 shares of the company’s stock worth $1,599,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Atomi Financial Group Inc. grew its stake in shares of Colgate-Palmolive by 12.8% during the third quarter. Atomi Financial Group Inc. now owns 6,095 shares of the company’s stock worth $633,000 after acquiring an additional 692 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Price Performance

Shares of CL opened at $100.80 on Wednesday. The stock has a market cap of $82.70 billion, a PE ratio of 31.84, a PEG ratio of 3.62 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The business has a 50-day simple moving average of $103.61 and a two-hundred day simple moving average of $97.02. Colgate-Palmolive has a 12-month low of $68.54 and a 12-month high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.77 earnings per share. Analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.98%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is currently 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. BNP Paribas started coverage on shares of Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 target price for the company. Stifel Nicolaus raised their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, July 22nd. Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Bank of America boosted their price objective on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Finally, Sanford C. Bernstein boosted their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $104.74.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.